Francesc Graus
#111,137
Most Influential Person Now
Researcher
Francesc Graus's AcademicInfluence.com Rankings
Francesc Grauscomputer-science Degrees
Computer Science
#4199
World Rank
#4419
Historical Rank
Algorithms
#129
World Rank
#130
Historical Rank
Machine Learning
#751
World Rank
#761
Historical Rank
Artificial Intelligence
#960
World Rank
#977
Historical Rank
Download Badge
Computer Science
Francesc Graus's Degrees
- PhD Computer Science University of Barcelona
- Masters Artificial Intelligence University of California, Berkeley
- Bachelors Computer Engineering University of Barcelona
Similar Degrees You Can Earn
Why Is Francesc Graus Influential?
(Suggest an Edit or Addition)Francesc Graus's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A clinical approach to diagnosis of autoimmune encephalitis (2016) (2278)
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study (2013) (2210)
- Recommended diagnostic criteria for paraneoplastic neurological syndromes (2004) (1200)
- Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series (2010) (918)
- Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients (1992) (806)
- Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. (2001) (802)
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen (2010) (762)
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location (2009) (708)
- Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study (2014) (701)
- Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. (2005) (650)
- Antibody-Mediated Encephalitis. (2018) (613)
- Clinical analysis of anti-Ma2-associated encephalitis. (2004) (598)
- Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. (2008) (525)
- Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. (2012) (504)
- Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies (2014) (484)
- Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force (2010) (453)
- Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force (2011) (437)
- Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis (2014) (402)
- Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. (2001) (386)
- Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone (2000) (381)
- Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. (2013) (372)
- Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia (2011) (370)
- Neuronal antinuclear antibody in sensory neuronopathy from lung cancer (1985) (368)
- A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study (2014) (357)
- Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. (2017) (357)
- Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. (1997) (350)
- Antibodies and neuronal autoimmune disorders of the CNS (2010) (347)
- Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. (2015) (347)
- An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models (2019) (334)
- Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. (1997) (333)
- Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. (2001) (332)
- Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. (1986) (324)
- Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis (2018) (324)
- Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. (2010) (312)
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. (2015) (303)
- Management of paraneoplastic neurological syndromes: report of an EFNS Task Force (2006) (288)
- Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies (2000) (284)
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition (2012) (279)
- Encephalitis and antibodies to dipeptidyl‐peptidase–like protein‐6, a subunit of Kv4.2 potassium channels (2013) (277)
- Paraneoplastic neurological syndromes. (2012) (277)
- Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease (2003) (270)
- Limbic encephalitis and small cell lung cancer. Clinical and immunological features. (1997) (267)
- The clinical spectrum of Caspr2 antibody–associated disease (2016) (261)
- GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders (2011) (258)
- Encephalitis and GABAB receptor antibodies (2013) (257)
- Autoantibodies in paraneoplastic syndromes associated with small‐cell lung cancer (1988) (257)
- Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease (2015) (243)
- Cerebrovascular Complications in Patients with Cancer (1985) (239)
- Detection of the anti‐Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy (1991) (226)
- Hyperintense globus pallidus on T1‐weighted MRI in cirrhotic patients is associated with severity of liver failure (1993) (226)
- P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer (2002) (223)
- Analysis of relapses in anti-NMDAR encephalitis (2011) (220)
- Clinical manifestations of the anti-IgLON5 disease (2017) (217)
- Autoimmune post–herpes simplex encephalitis of adults and teenagers (2015) (214)
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies (2008) (213)
- EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force (2006) (206)
- Neuronal surface antigen antibodies in limbic encephalitis (2008) (204)
- SOX1 antibodies are markers of paraneoplastic Lambert–Eaton myasthenic syndrome (2008) (203)
- Investigations in GABAA receptor antibody-associated encephalitis (2017) (201)
- Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. (2005) (199)
- Rapid eye movement sleep behavior disorder and potassium channel antibody–associated limbic encephalitis (2006) (190)
- Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas (2005) (190)
- Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. (1996) (187)
- Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen (1985) (185)
- Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease (1997) (183)
- SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. (2009) (181)
- Encephalitis and AMPA receptor antibodies (2015) (180)
- Clinical outcome of patients with anti-Hu–associated encephalomyelitis after treatment of the tumor (1999) (172)
- Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity (1997) (172)
- Motor neuron syndromes in cancer patients (1997) (172)
- Plasma exchange for acute attacks of CNS demyelination (2009) (169)
- Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. (1990) (166)
- Voltage‐gated potassium channel antibodies in limbic encephalitis (2003) (165)
- Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. (2002) (164)
- Opsoclonus, Myoclonus, Ataxia, and Encephalopathy in Adults with Cancer: A Distinct Paraneoplastic Syndrome (1988) (162)
- Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia (1996) (162)
- Anti-LGI1–associated cognitive impairment (2016) (160)
- Major histocompatibility proteins, anti‐Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer (1995) (159)
- Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas (2003) (158)
- Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes (2021) (150)
- Late-onset anti–NMDA receptor encephalitis (2013) (149)
- Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model (1991) (149)
- Hematopoietic stem cell transplantation for multiple sclerosis (2002) (148)
- Utility of anti‐Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy (1998) (146)
- Autologous haematopoietic-stem-cell transplantation for multiple sclerosis (2005) (146)
- Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration (1986) (144)
- A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis (2018) (142)
- Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis (2002) (141)
- Autoantigen diversity in the opsoclonus‐myoclonus syndrome (2003) (141)
- Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors (2019) (138)
- Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. (2014) (138)
- THE EXPANDING CLINICAL PROFILE OF ANTI-AMPA RECEPTOR ENCEPHALITIS (2010) (137)
- Primary CNS lymphoma with intraocular involvement (2008) (137)
- Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis (2014) (136)
- Neuropathological criteria of anti-IgLON5-related tauopathy (2016) (135)
- Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies. (2016) (134)
- Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. (2014) (133)
- Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. (2002) (133)
- The expanding field of IgG4‐mediated neurological autoimmune disorders (2015) (132)
- Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. (2015) (132)
- Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy (2000) (132)
- Antiglycine-receptor encephalomyelitis with rigidity (2010) (132)
- Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. (2015) (130)
- Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis (1990) (129)
- Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study (2020) (126)
- Selective expression of Purkinje‐cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration (1991) (120)
- Spectrum of paraneoplastic disease associated with lymphoma (2011) (118)
- Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer (2004) (118)
- Ephrin‐B2 prevents N‐methyl‐D‐aspartate receptor antibody effects on memory and neuroplasticity (2016) (117)
- CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. (2003) (117)
- Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer (2003) (116)
- Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder. (2016) (113)
- Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies (1995) (112)
- Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity (2015) (111)
- Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient (2020) (109)
- Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies (1992) (109)
- Autoimmune seizures and epilepsy. (2019) (108)
- Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes (2016) (108)
- Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis (2007) (108)
- Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromes (2005) (107)
- Salvage treatment with etoposide (VP‐16), ifosfamide and cytarabine (Ara‐C) for patients with recurrent primary central nervous system lymphoma (2003) (105)
- Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid (2018) (105)
- Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease? (2010) (104)
- Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia (2012) (103)
- Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. (1993) (102)
- MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS (2001) (101)
- Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma (1999) (100)
- LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy (2019) (99)
- Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. (2015) (99)
- Central nervous system involvement in mantle cell lymphoma. (2008) (97)
- Detection of 14‐3‐3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders (1999) (97)
- Indolent anti‐Hu‐associated paraneoplastic sensory neuropathy (1994) (97)
- Brain metastases in children. (1983) (94)
- REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. (2007) (94)
- Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor (2018) (94)
- Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. (2004) (93)
- Human neurexin-3α antibodies associate with encephalitis and alter synapse development (2016) (92)
- DPPX antibody–associated encephalitis (2017) (90)
- Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study (2009) (89)
- High ethanol consumption as risk factor for intracerebral hemorrhage in young and middle-aged people. (1990) (88)
- Predictive factors of in‐hospital CNS complications following liver transplantation (1994) (88)
- Syndrome and outcome of antibody‐negative limbic encephalitis (2018) (84)
- GAD antibodies in neurological disorders — insights and challenges (2020) (83)
- Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. (1991) (83)
- CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. (2001) (81)
- An antineuronal autoantibody in paraneoplastic opsoclonus (1988) (80)
- Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. (1996) (80)
- Cerebral infarction of the basal ganglia due to embolism from the heart. (1983) (80)
- Anti-Hu-associated brainstem encephalitis (2008) (80)
- Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS (2004) (80)
- Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies (2012) (79)
- Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study (2012) (78)
- Antibody-associated CNS syndromes without signs of inflammation in the elderly (2017) (78)
- CNS involvement in mantle-cell lymphoma. (1996) (78)
- Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. (2008) (77)
- Detection of 14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy (2000) (77)
- Relapsing neuromyelitis optica: long term history and clinical predictors of death (2009) (76)
- Neuromyelitis optica spectrum disorders (2016) (75)
- Paraneoplastic neurological syndromes: diagnosis and treatment (2007) (75)
- Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program (2019) (75)
- CNS Hodgkin lymphoma. (2008) (74)
- Neuronal antinuclear antibody (anti‐Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis (1987) (73)
- Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain. (2013) (73)
- Hyperintensity in the globus pallidus on T1‐weighted and inversion‐recovery MRI (1991) (73)
- Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome (2016) (72)
- Stiff‐leg syndrome: A focal form of stiff‐man syndrome (1998) (72)
- Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates (2018) (72)
- Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. (2003) (72)
- Epilepsia partialis continua: A new manifestation of anti‐Hu–associated paraneoplastic encephalomyelitis (1999) (71)
- Encephalitis with mGluR5 antibodies (2018) (70)
- Revised diagnostic criteria for neuromyelitis optica (NMO) (2007) (69)
- 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis (2001) (69)
- Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience (2011) (69)
- P/Q-type calcium channel antibodies, Lambert–Eaton myasthenic syndrome and survival in small cell lung cancer (2005) (67)
- Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes (1990) (66)
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study (2013) (66)
- Efficacy of radiotherapy for malignant gliomas in elderly patients. (1998) (65)
- Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. (1997) (64)
- Neurological Complications of Transplantation (2008) (63)
- Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer (2013) (62)
- Acute quadriplegic myopathy with myosin-deficient muscle fibres after liver transplantation: defining the clinical picture and delimiting the risk factors. (1999) (62)
- Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies (2020) (61)
- Validation of the new graded prognostic assessment scale for brain metastases: a multicenter prospective study (2011) (61)
- Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation (2001) (61)
- Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis (2020) (60)
- Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. (1990) (60)
- Rapidly progressive diffuse Lewy body disease (2011) (60)
- Auto antibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus (1986) (60)
- Hashimoto encephalopathy in the 21st century (2019) (59)
- Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies (2018) (59)
- Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. (2007) (59)
- Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies (2009) (58)
- Sleep disorder, chorea, and dementia associated with IgLON5 antibodies (2015) (57)
- Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies (2017) (56)
- Pure sensory neuropathy in patients with primary Sjögren's syndrome: clinical, immunological, and electromyographic findings. (1990) (56)
- Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease. (2014) (55)
- X‐Ray‐Induced Cell Death in the Developing Hippocampal Complex Involves Neurons and Requires Protein Synthesis (1993) (55)
- Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia (2007) (55)
- Carbonic anhydrase–related protein VIII: Autoantigen in paraneoplastic cerebellar degeneration (2004) (54)
- Normal proprioceptive trigeminal afferents in patients with Sjögren's syndrome and sensory neuronopathy (1990) (54)
- GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma. (2017) (53)
- Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour (1997) (52)
- A novel treatment‐responsive encephalitis with frequent opsoclonus and teratoma (2014) (52)
- Impact of radiotherapy delay on survival in glioblastoma (2013) (51)
- Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome. (2013) (51)
- Sensory neuronopathy and Sjögren's syndrome (1988) (50)
- Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma (2001) (50)
- Effect of glatiramer acetate (Copaxone®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study (2006) (49)
- Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system (1998) (49)
- Patient with homer-3 antibodies and cerebellitis. (2013) (49)
- IgLON5 autoimmunity and abnormal behaviours during sleep (2015) (49)
- Autoimmunity in Paraneoplastic Neurological Syndromes (1999) (47)
- Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-D-aspartate receptor antibodies are part of the problem (2013) (46)
- Cognitive functions in multiple sclerosis: impact of gray matter integrity (2014) (45)
- Antibodies against the calcium channel β‐subunit in Lambert‐Eaton myasthenic syndrome (1998) (45)
- Response to immunotherapy in CLIPPERS syndrome (2011) (45)
- Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody (1984) (44)
- Neurologic complications of hematopoietic cell transplantation. (2010) (44)
- The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons (1993) (43)
- Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis (2004) (43)
- Analysis of a neuronal antigen (Hu) expression in the developing rat brain detected by autoantibodies from patients with paraneoplastic encephalomyelitis (1990) (42)
- Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration (2020) (42)
- Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia (2014) (42)
- Subacute cerebellar syndrome as the first manifestation of AIDS dementia complex (1990) (41)
- Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias (2020) (41)
- Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes (2004) (41)
- Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature (1997) (41)
- Analysis of prognostic factors associated with longitudinally extensive transverse myelitis (2013) (41)
- Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration (2003) (41)
- An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays (2013) (40)
- Anti‐Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity (1994) (39)
- White matter abnormalities in primary Sjögren syndrome. (2012) (39)
- ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer (2008) (39)
- Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study (2006) (39)
- Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience (2014) (38)
- Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice (2013) (38)
- Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour (2007) (38)
- Guillain‐Barre syndrome associated with seroconversion for anti‐HTLV‐I11 (1987) (37)
- Protein kinase Cγ autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer (2006) (37)
- T‐cell reactivity to glutamic acid decarboxylase in stiff‐man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity (2002) (37)
- Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. (2016) (36)
- Late-onset neuromyelitis optica spectrum disorder (2019) (36)
- The palmomental reflex. Clinical study of 300 cases. (1984) (36)
- Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas (1997) (36)
- Neurological complications of hematopoietic cell transplantation. (2004) (36)
- Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series (2015) (35)
- The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested (2020) (35)
- Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies (2012) (34)
- HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease (2019) (34)
- Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies (2005) (34)
- BR serine/threonine kinase 2: A new autoantigen in paraneoplastic limbic encephalitis (2005) (34)
- Clinical significance of Kelch-like protein 11 antibodies (2020) (34)
- Paraneoplastic movement disorders (2009) (34)
- Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders (2008) (33)
- Stiff-man syndrome with vacuolar degeneration of anterior horn motor neurons (1999) (33)
- Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes. (2018) (33)
- Sleep disorders in autoimmune encephalitis (2020) (33)
- Selective concentration of anti‐Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration (1988) (33)
- Midbrain lesions and paroxysmal dysarthria in multiple sclerosis (2008) (33)
- Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study. (2007) (32)
- Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis (2020) (32)
- Intrathecal synthesis of the anti‐Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy (1994) (32)
- Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis (2021) (31)
- 'Hot and dry foot' as initial manifestation of neoplastic lumbosacral plexopathy (1989) (31)
- Anti‐Ri‐associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer (1993) (31)
- Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration. (2012) (30)
- Delayed onset of a second paraneoplastic neurological syndrome in eight patients (2010) (30)
- Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study (2016) (30)
- Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation. (1994) (29)
- Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. (2006) (29)
- Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: An autopsy case study (2008) (29)
- CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS (2004) (29)
- Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis (2021) (29)
- Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. (2015) (28)
- 14-3-3 protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt–Jakob disease (2002) (28)
- Clinical and genetic features of human prion diseases in Catalonia: 1993–2002 (2004) (28)
- Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies (2006) (28)
- Central motor conduction time in patients with multifocal motor conduction block (1999) (27)
- The Sleep Disorder in Anti-lgLON5 Disease (2018) (27)
- Limbic encephalitis (2008) (27)
- [Limbic encephalitis: a probably under-recognized syndrome]. (2005) (27)
- Sleep disorders in anti-NMDAR encephalitis (2020) (26)
- [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis]. (2008) (25)
- Papilledema in the metastatic jugular foramen syndrome. (1983) (25)
- [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica]. (2011) (25)
- Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2 (2019) (25)
- Absence of REM sleep, altered NREM sleep and supranuclear horizontal gaze palsy caused by a lesion of the pontine tegmentum. (1993) (25)
- Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy (2012) (24)
- Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis (2017) (24)
- Carbonic anhydrase‐related protein VIII antibodies and paraneoplastic cerebellar degeneration (2014) (24)
- Clinical Features, Treatment, and Outcome of 500 Patients with Anti-NMDA Receptor Encephalitis (PL01.001) (2012) (24)
- Paraneoplastic neuropathies (2013) (23)
- Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. (1986) (23)
- The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction (2003) (23)
- Ribosomal Multi-Operon Diversity: An Original Perspective on the Genus Aeromonas (2012) (23)
- Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy. (2007) (23)
- Opsoclonus–myoclonus syndrome and limbic encephalitis associated with GABAB receptor antibodies in CSF (2014) (23)
- Diagnosis and significance of antibody titers in anti-NMDA receptor encephalitis, a retrospective study (2014) (23)
- No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis (2006) (23)
- Delayed apperance of anti–myelin‐associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy (1993) (23)
- Pre-irradiation semi-intensive chemotherapy with carboplatin and cyclophosphamide in malignant glioma: a phase II study (2002) (23)
- Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis (2020) (23)
- Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration (2015) (22)
- Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease (2021) (22)
- Neurological Complications of Solid Organ Transplantation (2013) (22)
- Characterization of the sleep disorder of anti-IgLON5 disease. (2019) (22)
- Cyclosporine-associated mutism in liver transplant patients (1996) (22)
- Mixed carcinomatous neuropathy in patients with lung cancer and lymphoma (1983) (21)
- CNS autoimmunity: new findings and pending issues (2012) (21)
- Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations? (2008) (21)
- Intracranial tuberculomas in patients with AIDS. (1991) (21)
- Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonus (2008) (21)
- Diagnosis and Treatment of Paraneoplastic Neurological Disorders (2004) (21)
- No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis (2003) (21)
- Expression of lymphocyte, macrophage and class I and II major histocompatibility complex antigens in normal human dorsal root ganglia (1990) (21)
- No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis (2001) (20)
- Pregnancy outcomes in anti-NMDA receptor encephalitis (2020) (20)
- Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells (2012) (19)
- Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis (2021) (19)
- Partial Brown-Séquard's syndrome and meningococcal meningitis. (1981) (19)
- Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies (2017) (19)
- Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis (2004) (18)
- Walking function in clinical monitoring of multiple sclerosis by telemedicine (2015) (18)
- Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis (2012) (18)
- Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma (2017) (18)
- Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis – Authors' reply (2016) (18)
- Understanding anti-IgLON5 disease (2017) (18)
- Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis (2019) (18)
- Immunohistochemical localization of la nuclear antigen in brain Selective concentration of the la protein in neuronal nucleoli (1985) (18)
- Pitfalls in the detection of CV2 (CRMP5) antibodies (2016) (18)
- Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes (2016) (18)
- Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis (2005) (17)
- Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis (2015) (17)
- Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis (2014) (17)
- T2 hypointense rims and ring-enhancing lesions in MS (2010) (17)
- Hu-antibody-positive patients with or without cancer have similar clinical profiles (2006) (17)
- Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study (2020) (17)
- Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation. (2017) (17)
- OPSOCLONUS AND OAT CELL CARCINOMA OF LUNG: LACK OF EVIDENCE FOR ANTI-CNS ANTIBODIES (1984) (16)
- Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration (2013) (16)
- Anti-IGLON5 disease (2019) (16)
- A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies (2019) (16)
- EFNS Task Force Report: a questionnaire‐based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres (2000) (16)
- Cerebrovascular complications in patients with cancer. (1985) (16)
- [Copper deficiency myelopathy]. (2008) (15)
- Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block (1995) (15)
- Sensory neuropathy as the initial manifestation of primary biliary cirrhosis. (1989) (15)
- Cognitive and brain structural changes in long-term oligodendroglial tumor survivors. (2019) (15)
- A monoclonal antibody that induces T cell aggregation reacts with vascular endothelial cells and placental trophoblasts. (1986) (15)
- Primary brain lymphomas after kidney transplantation: an under-recognized problem? (2014) (15)
- Central hypoventilation as the presenting symptom in Hu associated paraneoplastic encephalomyelitis (2007) (15)
- Immune modulation of paraneoplastic neurologic disorders (1995) (15)
- Antibody testing in peripheral nerve disorders. (2013) (15)
- Adult-onset mitochondrial myopathy. (1992) (15)
- Pediatric Anti-NMDAR encephalitis-Clinical analysis and novel findings in a series of 20 patients (2013) (14)
- Radiosensitive populations and recovery in X-ray-induced apoptosis in the developing cerebellum (2004) (14)
- Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance (2001) (14)
- [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease]. (1998) (14)
- Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations (2019) (14)
- Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies (2018) (14)
- The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia (2001) (14)
- Voltage-gated potassium channel antibodies (2016) (14)
- Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease. (2019) (14)
- Seizure-related 6 homolog like 2 autoimmunity (2020) (14)
- Sensory neuropathy as remote effect of cancer (1987) (13)
- Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies (2007) (13)
- Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis (2022) (13)
- Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors (1997) (13)
- Incidence and Impact of COVID-19 in MS (2021) (13)
- Clinical and pathological advances on central nervous system paraneoplastic syndromes. (1992) (13)
- Encephalitis and antibodies to DPPX , a subunit of Kv 4 . 2 potassium channels (2013) (12)
- The expression of a neuronal nuclear antigen (Ri) recognized by the human anti-Ri autoantibody in the developing rat nervous system (1993) (12)
- Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67) (2016) (12)
- Amyotrophic Lateral Sclerosis in a Patient ivith Systemic Lupus Erythematosus (1993) (12)
- Is the time interval between diagnosis and radiation treatment an important factor in brain metastases? (1996) (12)
- [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia]. (2007) (11)
- Antidisialosyl antibodies in chronic idiopathic ataxic neuropathy (2002) (11)
- [Fast and spectacular clinical response to plasmapheresis in a paediatric case of anti-NMDA encephalitis]. (2012) (11)
- Hypoglycemic seizures and epilepsy in type I diabetes mellitus (2014) (11)
- Seizure‐susceptible brain regions in glioblastoma: identification of patients at risk (2018) (10)
- [Compression of the spinal cord by the amyloid tissue in the thoracic vertebral amyloidoma]. (1994) (10)
- Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2 (2021) (10)
- [Diagnosis of Creutzfeldt-Jakob disease by spinal fluid analysis]. (1997) (10)
- Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis (2016) (10)
- LACK OF EFFICACY OF CONVALESCENT PLASMA IN COVID-19 PATIENTS WITH CONCOMITANT HEMATOLOGICAL MALIGNANCIES AN ITALIAN RETROSPECTIVE STUDY. (2022) (10)
- [Central nervous system involvement in primary Sjögren syndrome]. (2009) (10)
- Sporadic MM2‐thalamic + cortical Creutzfeldt‐Jakob disease: Utility of diffusion tensor imaging in the detection of cortical involvement in vivo (2016) (10)
- Does gender matter in glioblastoma? (2011) (9)
- Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes (2017) (9)
- Guillain-Barré syndrome associated with seroconversion for anti-HTLV-III. (1987) (9)
- ACUTE NECROTIC MYELOPATHY ASSOCIATED WITH INFLUENZA VACCINATION (1987) (9)
- Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience. (2003) (9)
- Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias (2020) (9)
- A novel NREM and REM parasomnia with sleep breathing disorder associated with antibodies against IgLON 5 : a case series , pathological features , and characterization of the antigen (2014) (9)
- [NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases]. (2006) (8)
- The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders (2019) (8)
- Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer. (1998) (8)
- Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients. (2001) (8)
- [Paragonimiasis and pulmonary tuberculosis]. (1992) (8)
- Paraneoplastic opsomyoclonus, cerebellar ataxia and encephalopathy associated with anti-Purkinje cell antibodies (1997) (7)
- Concomitant and adjuvant temozolomide (TMZ) and whole brain irradiation (WBI) on patients affected with brain metastases (BM): a randomized multicentric phase II trial (2003) (7)
- [Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung]. (1986) (7)
- Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies (2002) (7)
- Isolated frontal disequilibrium as presenting form of anti‐Hu paraneoplastic encephalomyelitis (2007) (7)
- [Paraneoplastic syndromes in otoneuro-ophthalmology]. (2000) (7)
- Autoimmune encephalitis with GABAA receptor antibodies in a 10-year-old girl (2018) (7)
- Trends and survival for AIDS patients presenting with indicative neurologic diseases (1991) (7)
- [Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG)]. (2010) (7)
- Amyotrophic lateral sclerosis in a patient with systemic lupus erythematosus. (1993) (7)
- Action myoclonus as an early clinical sign of carcinomatous meningitis (1996) (7)
- SELNET Clinical practice guidelines for soft tissue sarcoma and GIST (2021) (7)
- Steroid-dependent anti-Hu negative paraneoplastic encephalomyelitis and small cell lung carcinoma (1998) (6)
- Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites (1995) (6)
- Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?–Authors' reply (2014) (6)
- Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination (2015) (6)
- Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy (2018) (6)
- [Wolfram's syndrome: correlation of clinical signs and neurological images]. (1995) (6)
- Anti-Hu-associated paraneoplastic sensory neuropathy and breast cancer (2000) (6)
- [Progressive multifocal leukoencephalopathy]. (1989) (6)
- Acute Meningospinal Syndromes: Acute Myelopathy and Radiculopathy (1990) (6)
- TI-201 SPECT in pseudotumoral multiple sclerosis. (1999) (5)
- Autoantibody (anti‐Hu) seronegativity (1994) (5)
- [Cerebral metastasis of melanoma: study of 48 patients]. (1993) (5)
- Autoimmune Encephalitis and Related Disorders of the Nervous System (2022) (5)
- Antibody-mediated Neuropsychiatric Disorders. (2021) (5)
- Episodic hyperhidrosis as the only clinical manifestation of neuromyotonia (2005) (5)
- Glycine receptor antibodies and progressive encephalomyelitis with rigidity and myoclonus with predominant motor neuron degeneration — Expanding the clinical spectrum (2015) (5)
- Clinical and immunohistochemical comparison of in vivo injected anti‐Hu and control IgG in the nervous system of the mouse (1996) (5)
- Human N-methyl-d-aspartate receptor antibodies alter memory and behavior in a passive ventricular murine infusion model (2014) (5)
- Absence of GluD2 Antibodies in Patients with Opsoclonus-Myoclonus Syndrome. (2020) (5)
- Anti-GAD epileptic encephalopathy in a toddler with Parry-Romberg syndrome (2019) (5)
- Guidelines on the Management of Low-grade Gliomas: EANO Task Force Report (2012) (4)
- Paraneoplastic stiff person syndrome with small cell carcinoma of the bladder and anti-Ri antibodies (2018) (4)
- Discrepancies in the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. (2004) (4)
- Neuronal antibodies in Creutzfeldt-Jakob disease - reply. (2014) (4)
- Antibodies in acquired demyelinating disorders in children (2016) (4)
- Screening for Tumours in Paraneoplastic Syndromes (2011) (4)
- Thymoma and Autoimmune Encephalitis Clinical Manifestations and Antibodies (4)
- Thymoma and Autoimmune Encephalitis (2021) (4)
- Recommended diagnostic criteria for paraneoplastic neurological syndromes. Commentary (2004) (4)
- [Postherpetic vasculopathy. A study of 3 cases in immunosuppressed patients]. (1990) (3)
- Bilateral asterixis in unilateral subdural hematoma (2004) (3)
- Leptomeningeal amyloidosis due to A25T TTR mutation: a case report. (2014) (3)
- Development of amyotrophic lateral sclerosis in the course of systemic lupus erythematosus (1992) (3)
- Paraneoplastic cerebellar degeneration associated with thymic germinoma (2012) (3)
- [Primary cerebral lymphoma in 10 patients with AIDS. Comparative clinico-radiologic study with cerebral toxoplasmosis, cerebral tuberculoma and primary cerebral lymphoma in non-immunodepressed patients]. (1992) (3)
- Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice (2022) (3)
- [Neurologic syndromes associated with anti-Hu antibody. Study of 24 patients]. (1992) (3)
- [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]. (1990) (3)
- Neuro-oncology: setting new standards of management (2006) (3)
- A novel non-rapid-eye movement (REM) and REM parasomnia with sleep breathing disorder associated with antibodies to IgLON5 and tau deposits at post-mortem study (2014) (3)
- Use of Antibody Testing in Nervous System Disorders (2010) (3)
- Myasthenia gravis coincident with papillary thyroid carcinoma: absent expression of the α-subunit of the acetylcholine receptor in the tumour (1995) (3)
- Twenty-third Meeting of the European Neurological Society, 8–11 June, 2013 Barcelona, Spain (2013) (3)
- [Transplantation of haematopoietic stem cells in multiple sclerosis]. (2002) (3)
- (Pseudo)hemidystonia associated with anti‐glutamic acid decarboxylase antibodies – a case report (2015) (3)
- Toxoplasmic encephalitis with normal CT scan and pathologic MRI. (1995) (3)
- Paraneoplastic syndromes: from remote to clear and present knowledge (2012) (3)
- Interleukin-22 and Chemokine Interferon γ -Inducible-10 (IP-10) Levels in Chronic Hepatitis C Patients and Treatment Response to Pegylated Interferon and Ribavirin Therapy. (2017) (3)
- Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma (2016) (3)
- [Tropical spastic paraparesis and HTLV-I. The first case in Spain]. (1991) (3)
- Clinical findings, IgG subclass, and antibody effects in encephalitis associated with metabotropic glutamate receptor 5 (mGluR5) antibodies (P5.390) (2018) (2)
- State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis (2020) (2)
- [The Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of a nonparaneoplastic origin: a review of a case 4 years later]. (1999) (2)
- [Choriocarcinoma presenting as cerebral infarction due to tumor embolism]. (1994) (2)
- [Meningoencephalomyelitis caused by Borrelia burgdorferi: a case without epidemiologic history or chronic migratory erythema]. (1989) (2)
- Widening the spectrum of inflammatory disorders of the central nervous system. (2017) (2)
- Autoimmune Encephalitis-Misdiagnosis, Misconceptions, and How to Avoid Them. (2022) (2)
- [Pruritus as initial manifestation of a paraneoplastic stiff person syndrome associated to anti-amphiphysin antibodies]. (2009) (2)
- [Contribution of magnetic resonance imaging in the early diagnosis of epidural metastasis]. (1992) (2)
- [Subacute deafness in encephalomyelitis and paraneoplastic sensory neuropathy]. (1997) (2)
- Prospective validation of the new graded prognostic assessment scale for brain metastases: A multicenter study. (2010) (2)
- Comparative Toxicity of Copper Oxide Nanoparticles and Dissolved Copper to Freshwater Mussels (2019) (2)
- [Clinical and immunological profile of limbic encephalitis associated with voltage-gated potassium channel antibodies]. (2009) (2)
- Electrophysiologic study of patients with pure sensory neuropathy (1990) (2)
- [Cranial neuropathy and cancer]. (1986) (1)
- In response to Drs. Ferreri and Reni (2005) (1)
- Author Response: Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis (2021) (1)
- Contribution of Trans-Synaptic Neuronal Degeneration to Retinal Atrophy in MS (P01.161) (2012) (1)
- Novel Findings in Anti-GABAa Receptor Encephalitis (P3.004) (2016) (1)
- P17.02 Diagnostic delay and treatment options of Primary Central Nervous System Lymphoma in the last decade: preliminary results of first 50 patients from two Catalan institutions. (2016) (1)
- Volumetric and shape analysis of the hippocampus in temporal lobe epilepsy with GAD65 antibodies compared with non-immune epilepsy (2021) (1)
- EXPRESSION OF THE CUTANEOUS LYMPHOCYTE ANTIGEN (CLA/HECA-452) IN THE INFLAMMATORY INFLTRATES OF SKIN AND MUSCLE LESIONS OF DERMATOMYOSITIS. A DOUBLE IMMUNOFLUORESCENCE STUDY. (1998) (1)
- Interaction between Pseudomonas aeruginosa and Dermatophyte Fungi: Repercussions on the Clinical Course and Microbiological Diagnosis of Tinea Pedis (2017) (1)
- [Spinal cord compression in cancer patients]. (1997) (1)
- Spondylotic myelopathy mimicking myelitis: diagnostic clues by magnetic resonance imaging. (2015) (1)
- WHO Guidelines for Diagnosis of Glial Tumours : What Is Old and What Is New ? (2011) (1)
- Is There Any Association between Blood Group and Impacted Third Molars? (1)
- [Lumbosacral plexopathy in patients with cancer]. (1988) (1)
- [Autoimmune paraneoplastic cerebellar degeneration]. (1994) (1)
- Vanishing spinal cord after varicella-zoster virus myelitis (2017) (1)
- OS08.9 Management of Primary Central Nervous System Lymphoma in Spain in the last decade: a case series of the Spanish Group of Neuro-Oncology and GELTAMO (2017) (1)
- Is the Second Phase of the Formalin Test Useful to Predict Activity in Chronic Constriction Injury Models? A Pharmacological Comparison in Different Species (2003) (1)
- Paraneoplastic neuropathies. (1993) (1)
- [Paraneoplastic retinopathy and anti-recoverin antibodies]. (2002) (1)
- [Anti-Tr antibodies and cerebellar paraneoplastic degeneration associated with Hodgkin's disease]. (1996) (1)
- Epstein-Barr Virus Infection-Associated Renal Disease : Diagnostic Use of Molecular Hybridization Technology in Patients with Negative Serology 1 (2005) (1)
- Cerebral amyloid angiopathy, leukoencephalopathy and dementia of acute onset. Clinicopathological study of a new case (1995) (1)
- [Cerebroretinal microangiopathy]. (1994) (1)
- Supermagnetic Iron Oxide Tracer in Association with Radioisotope, for Sentinel Node Biopsy in Patients with Complete Axillary Response, After Neoadjuvant Chemoterapy: A Single Center, Prospective Study (2021) (1)
- [Neuroradiological changes in a case of lumbosacral polyradiculopathy caused by cytomegalovirus in a patient with AIDS]. (1995) (1)
- Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome (2015) (1)
- Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature (2022) (1)
- Bipolar-associated miR-499-5p controls neuroplasticity by downregulating the Cav1.2 L-type voltage gated calcium channel subunit CACNB2 (2021) (1)
- Novel findings in autoimmune encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) (P1.333) (2017) (1)
- [Surgical treatment combined with radiotherapy and chemotherapy in an unselected population of patients with malignant glioma]. (1993) (1)
- Author response: Hashimoto encephalopathy in the 21st century (2020) (1)
- Editorial: Widening the spectrum of inflammatory disorders of the central nervous system: an update on autoimmune neurology. (2019) (1)
- Towards a better recognition of paraneoplastic brainstem encephalitis (2021) (1)
- [MM1 variant of sporadic Creutzfeldt-Jakob disease with long duration akinetic mutism state]. (2006) (1)
- Retinopatía paraneoplásica y anticuerpos antirrecoverina (2002) (1)
- Lack of association between human leukocyte antigens and the anti‐Hu syndrome in patients with small‐cell lung cancer (1998) (1)
- Zinc binding to the gills of rainbow trout : the e ff ect of long-term exposure to sublethal zinc (1998) (1)
- [Non-valvular auricular fibrillation, cerebral embolism and anticoagulant treatment]. (1987) (0)
- Relation of Fatty Acid Attachment to the Translation and Maturation of Vesicular Stomatitis and Sindbis Virus Membrane Glycoproteins* (2001) (0)
- Neurolathyrism With Deep Vein Thrombosis and Bony Exostosis: Are They New Forms of Angiolathyrism and Osteolathyrism? (2022) (0)
- Pharmacodynamics and safety of human recombinant luteinising hormone (LH) in hypogonadotropic hypogonadal men: a new ongoing multicenter study (2022) (0)
- New GRINL1A Protein Interacts with NMDA Receptor and May Modulate Activity (2005) (0)
- Comparing Lymphocyte Radiosensitivity of Prostate Cancer Patients with Healthy Donors Using Micronuclei and Chemical Premature Chromosome Condensation Tests (2020) (0)
- Management of Adnexal Masses During Pregnancy: A Literature Review (2018) (0)
- Analysis of perfusion MR changes in radiated white matter (2012) (0)
- Reply from the Authors (1990) (0)
- [Carcinomatous leptomeningitis as a complication of solid tumors. Presentation of 17 cases]. (1987) (0)
- Use of Anti‐Nerve Antibodies (2008) (0)
- [Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1]. (1992) (0)
- Identification of a Novel Phenotype of Opsoclonus-Myoclonus Syndrome (OMS) That Affects Teenagers and Young Adults and Responds to Treatment (S56.006) (2013) (0)
- [Sensory neuropathy and primary Sjögren syndrome]. (1988) (0)
- P14.102 Cerebellar atrophy patterns in paraneoplastic cerebellar degeneraiton and spinocerebellar ataxia 1 (SCA1) (2019) (0)
- P-085: THE MORBIDITY AND MORTALITY OF SICKLE CELL DISEASE PATIENTS IN THE HAEMATOLOGY DEPARTMENT OF THE IGNACE DEEN HOSPITAL, CONAKRY HOSPITAL AND UNIVERSITY CENTRE (2022) (0)
- Autoimmunity to Inhibitory Synaptic Proteins in Stiff-Person Spectrum of Symptoms (S52.003) (2014) (0)
- Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome (2016) (0)
- Cutanea tarda porphyria and hepatitis C virus (1994) (0)
- Author Correction: Volumetric and shape analysis of the hippocampus in temporal lobe epilepsy with GAD65 antibodies compared with non-immune epilepsy (2021) (0)
- Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO (2013) (0)
- Anti-NMDA Receptor Encephalitis in the Elderly Associates with Delays in Diagnosis, Treatment, and Worse Clinical outcome (IN10-2.003) (2013) (0)
- [Fever, polyarthritis, left hemiplegia and loss of consciousness in a 37-year-old man with T-cell lymphoma]. (1991) (0)
- Effects of High Glucose Concentrations on Human Mesangial Cell Proliferation1’2 (2005) (0)
- [New treatments in brain tumors]. (1999) (0)
- Primary Brain Lymphomas after Kidney Transplantation: An Under- Recognized Problem?: 762 (2012) (0)
- Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia (2014) (0)
- [Anti-NMDA receptor encephalitis in a four-year-old male]. (2011) (0)
- 4-12-01 Impairment cognitive behavior in antibody-positive (anti-yo) cerebellar degeneration. Evidence cerebello-cerebral diaschisis (1997) (0)
- High-dose chemotherapy (HDCT) with G-CSF support before radiotherapy (RT) in malignant gliomas (MG): phase II trial (1999) (0)
- STEM-08INHIBITION OF THE NEURAL STEM CELL/OLIGODENDROCYTE PROGENITOR FACTOR GPR56 PROMOTES THE PRONEURAL TO MESENCHYMAL TRANSITION AND RADIORESISTANCE IN GLIOBLASTOMA (2015) (0)
- Supplementary Material for: Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series (2016) (0)
- LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy (2019) (0)
- [Paraneoplastic encephalomyelitis and Lambert-Eaton syndrome]. (1992) (0)
- [Peripheral neuropathy and insulinoma (author's transl)]. (1981) (0)
- ENZYME COMPLEMENTATION IN VITRO BETWEEN ADENYLOSUCCINASELESS MUTANTS OF NEUROSPORA CRASSA * (0)
- Best oral presentation: Glioblastomas with complete resection: Changes in relative cerebral blood volume in white matter irradiated (2013) (0)
- Chapter 178 – Paraneoplastic Syndromes (2003) (0)
- [Status epilepticus caused by abstinence from lorazepam]. (1987) (0)
- [Kearns-Sayre syndrome. Description of a case]. (1988) (0)
- [Epidemiology of the forms of neurological presentation in patients with AIDS]. (1990) (0)
- Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies (2023) (0)
- [AIDS dementia complex as the 1st manifestation of the acquired immunodeficiency syndrome]. (1989) (0)
- [Incidence of Borrelia burgdorferi infection in isolated facial paralysis. A prospective study]. (1992) (0)
- [Usefulness of gadolinium in the diagnosis of spinal cord metastases]. (1991) (0)
- The clinical spectrum of frontotemporal dementia: A case of rapidly progressive (2016) (0)
- [Cerebellar degeneration associated with anti-Tr antibodies without Hodgkin's disease. Four years follow-up]. (2004) (0)
- Clinical and Immunologic Investigations in Patients With Stiff-Person SpectrumDisorder (2016) (0)
- MOGAD comes of age with new criteria (2023) (0)
- Puresensoryneuropathy inpatients withprimary Sjogren's syndrome: clinical, immunological, and electromyographi c findings (1990) (0)
- [Primary cerebral lymphomas: diagnostic and therapeutic aspects]. (1989) (0)
- [The survival of acquired immunodeficiency syndrome patients with neurological forms of presentation]. (1990) (0)
- [Tuberculous cerebral abscess and acquired immunodeficiency syndrome]. (1989) (0)
- Widening the spectrum of inflammatory disorders of the CNS: an update on autoimmune neurology (2019) (0)
- [Neuropathy of the brachial plexus in a patient with acute promyelocytic leukemia]. (1988) (0)
- Non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder, chorea and dementia associated with antibodies to IgLON5: Case Report (P2.010) (2016) (0)
- [Malaria and Lyme disease]. (1994) (0)
- [Progressive multifocal leukoencephalopathy as the first manifestation of acquired immunodeficiency syndrome. Apropos of 2 cases]. (1988) (0)
- Determination of Antibodies to GAD67 and Other Antigens in Patients with GAD65 Antibody-Associated Syndromes (P5.033) (2014) (0)
- Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2016) (0)
- P17.70CAN ELDERLY PATIENTS WITH GLIOBLASTOMA BENEFIT FROM CONVENTIONAL CHEMO-RADIOTHERAPY TREATMENT? (2014) (0)
- Short communication P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer (2005) (0)
- PO-0650 ANALYSIS OF PERFUSION MAGNETIC RESONANCE CHANGES IN RADIATED WHITE MATTER IN PATIENTS WITH GLIOBLASTOMA (2012) (0)
- [Peripheral neuropathies and cancer]. (1986) (0)
- Antibodies Against The Cell Adhesion Molecule IgLON5 Identify A Novel Tauopathy With NREM/REM Parasomnia And Sleep Breathing Disorder (S9.005) (2014) (0)
- Frequency and clinical significance of seronegative anti-NMDAR encephalitis (2418) (2020) (0)
- Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies-Reply. (2016) (0)
- [Implication of radiological pattern in the prognosis of oligodendroglial tumors: correlation with genetic profile]. (2011) (0)
- [Late systemic vasculitis in a patient with Cogan's syndrome]. (1988) (0)
- P11.06LYMPHOMATOSIS CEREBRI: A RARE FORM OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (2014) (0)
- Purkinje cell antibodies in a patient with cerebellar disorder (1992) (0)
- Targeting B Cells in Neurological Autoimmune Diseases (2014) (0)
- 693High grade gliomas in old patients (1996) (0)
- Anti-LGI1-Associated Cognitive Impairment: Clinical Profiles and Long-Term Outcome (P6.124) (2016) (0)
- [Cerebral infarct of arterial origin in meningitis caused by enterobacter. Apropos of a case]. (1989) (0)
- Small fast rhythmic eye movements (SFREM) misdiagnosed as frontal seizures (2016) (0)
- [Rapidly progressive dementia in a 69-year-old woman]. (1999) (0)
- Initial management of primary central nervous system lymphoma in Spain in the last decade. The experience of the GELTAMO and Spanish neuro‐oncology groups (2017) (0)
- Chapter 33. Brain Metastases (2008) (0)
- Contents Vol. 15, 2015 (2015) (0)
- Reply: Rapidly progressing diffuse Lewy body disease (2011) (0)
- [Recommendations on the multidisciplinary management in patients with malignant glioma]. (2001) (0)
- Treatment of syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone (2000) (0)
- Online Database Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2018) (0)
- Tumours and Paraneoplastic Syndromes (2018) (0)
- [AIDS dementia complex]. (1989) (0)
- Accuracy of Medical Terminology-Reply (1985) (0)
- Reply (2000) (0)
- [Preclivus tuberculous pachymeningitis]. (1994) (0)
- [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome]. (1998) (0)
- Neuronal antinuclear antibody in sensory neuronopathy from lung cancer (2011) (0)
- The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined (2022) (0)
- From Behavior To Synapse: A Murine Model Of Passive Transfer Of Antibodies From Patients With Anti-NMDAR Encephalitis (S63.007) (2014) (0)
- Antiganglioside antibodies in acute self‐limiting ataxic neuropathy: incidence and significance (2002) (0)
- Tumors and Paraneoplastic Syndromes (2010) (0)
- OP67 – 2451: Antibodies against neuronal surface antigens in children with inflammatory demyelinating diseases of the CNS (2015) (0)
- [Paraneoplastic stiff-person syndrome with antiamphiphysin antibodies with small-cell lung cancer]. (2009) (0)
- P07.07 Tumor location and seizure risk in glioblastoma population (2016) (0)
- Analysis of autoantibodies against antigens of the inhibitory synapses in patients with non-paraneoplastic neurological syndromes and GAD65 antibodies (2014) (0)
- NEURONAL NUCLEAR AUTOANTIBODIES, TYPE 1 (Hu) (2007) (0)
- [Spinal myoclonus with antibodies against glutamic decarboxylase]. (1998) (0)
- [Bilateral hemorrhagic infarction caused by tumoral thrombosis of the superior longitudinal sinus]. (1997) (0)
- Clinical characterization and outcome of 47 patients with neurologic adverse events of immune-checkpoint inhibitors (P4-5.026) (2023) (0)
- Antibodies to GABAa Receptor Associate With Seizures, Status Epilepticus, And Remove The Receptors From Synapses (P3.001) (2014) (0)
- [Spinal cord metastasis of carcinoma of the lung: evaluation of magnetic resonance and computed tomography in its diagnosis]. (1990) (0)
- Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome (2021) (0)
- PAQUIMENINGITIS PRECLIVAL TUBERCULOSA (1994) (0)
- [Hemangioma of the vertebrae: contribution of magnetic resonance to its study]. (1989) (0)
- [Paraneoplastic encephalomyelitis: value of anti-Hu antibody in its diagnosis]. (1991) (0)
- 2067 Malignant gliomas (MG) in the elderly. A study of 85 consecutive patients in two institutions (1997) (0)
- Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions (2023) (0)
- [Antigens and antigenic systems]. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Francesc Graus?
Francesc Graus is affiliated with the following schools:
